VNTH Stock Overview
Nano Mobile Healthcare, Inc. operates as a mobile health technology company in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Nano Mobile Healthcare, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0003 |
| 52 Week High | US$0.0006 |
| 52 Week Low | US$0.0001 |
| Beta | -0.24 |
| 1 Month Change | 0% |
| 3 Month Change | 20.00% |
| 1 Year Change | -33.33% |
| 3 Year Change | -76.92% |
| 5 Year Change | -25.00% |
| Change since IPO | -99.99% |
Recent News & Updates
Recent updates
Shareholder Returns
| VNTH | US Specialty Retail | US Market | |
|---|---|---|---|
| 7D | 50.0% | -0.8% | -0.7% |
| 1Y | -33.3% | 10.2% | 22.3% |
Return vs Industry: VNTH underperformed the US Specialty Retail industry which returned 11.5% over the past year.
Return vs Market: VNTH underperformed the US Market which returned 22.8% over the past year.
Price Volatility
| VNTH volatility | |
|---|---|
| VNTH Average Weekly Movement | 42.2% |
| Specialty Retail Industry Average Movement | 7.0% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: VNTH's share price has been volatile over the past 3 months.
Volatility Over Time: VNTH's weekly volatility has increased from 35% to 42% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | n/a | Roy Watson | n/a |
Nano Mobile Healthcare, Inc. operates as a mobile health technology company in the United States. The company develops personalized and point-of-care screening using applications based upon chemical sensing methods. It has a strategic partnership with Theranostics Laboratory, a translational research company.
Nano Mobile Healthcare, Inc. Fundamentals Summary
| VNTH fundamental statistics | |
|---|---|
| Market cap | US$982.13k |
| Earnings (TTM) | -US$1.47k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-668.1x
P/E RatioIs VNTH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VNTH income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$133.00 |
| Gross Profit | -US$133.00 |
| Other Expenses | US$1.34k |
| Earnings | -US$1.47k |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -99.3% |
How did VNTH perform over the long term?
See historical performance and comparison